MATINAS BIOPHARMA HOLDINGS, INC. Deferred Tax Assets, Operating Loss Carryforwards
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Deferred Tax Assets, Operating Loss Carryforwards of $33.36 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $33.36M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $28.27M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $25.15M.
- 2023-09-30: Deferred Tax Assets, Operating Loss Carryforwards $0.00.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $33.36M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $28.27M 10-K · filed 2026-03-31 | |
| 2023-12-31 | $25.15M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | |
| 2022-12-31 | $21.75M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $1.73M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.73M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $24.08M 10-K · filed 2023-03-15 | |
| 2020-12-31 | $19.93M 10-K/A · filed 2022-03-11 | |
| 2019-12-31 | $15.59M 10-K · filed 2021-03-29 | |
| 2018-12-31 | $12.27M 10-K · filed 2020-03-09 | |
| 2017-12-31 | $8.87M 10-K · filed 2019-04-01 | |
| 2016-12-31 | $9.07M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $7.09M 10-K · filed 2017-03-31 | $7.09M 10-K · filed 2016-03-30 |
| 2014-12-31 | $4.38M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $1.32M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |